Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2024

MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Significant Positive Results from LTE VISIONARY-MS Trial

Posted on January 8, 2024 by MissionIR

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including (“ALS”) and multiple sclerosis (“MS”), today … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

Astrotech Corp. (NASDAQ: ASTC) Announces New Mass Spectrometry Technology Application for Chemical Manufacturing and Introduces the Pro-Control Subsidiary

Posted on January 8, 2024 by MissionIR

Astrotech (NASDAQ: ASTC), is an instrumentation company that is focused on commercializing its proprietary ATi Mass Spectrometer Technology(TM) that is now used in airports and agriculture applications throughout the world. Astrotech continues to expand its ATi Mass Spectrometer Technology into … Continue reading →

Posted in Astrotech Corp. ASTC | Leave a comment

Turbo Energy (NASDAQ: TURB) Strategically Positioned for Growth in the Age of Artificial Intelligence

Posted on January 8, 2024 by MissionIR

In the midst of challenges faced by the self-consumption photovoltaic sector in 2023, Turbo Energy (NASDAQ: TURB), a Spain-based photovoltaic energy storage innovator, achieved notable achievements. Despite revenue decline due to headwinds like high interest rates and subsidy cuts affecting … Continue reading →

Posted in Turbo Energy S.A. TURB | Leave a comment

Correlate Energy Corp. (CIPI) Marks Successful Close to the Year with Commissioning of ATD’s Huntersville Headquarters Solar Project

Posted on January 8, 2024 by MissionIR

Correlate Energy (OTCQB: CIPI), successfully capitalizing on the continued corporate push for financially positive decentralized energy generation, just announced the successful commissioning a major solar project located in American Tire Distributors’ (“ATD”) Huntersville, North Carolina headquarters. This follows the successful … Continue reading →

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Commends and Supports U.S. Policymakers for the National Defense Authorization Act

Posted on January 5, 2024 by MissionIR

D-Wave Quantum (NYSE: QBTS), the world’s first commercial supplier of quantum computers, software, and services, commends U.S. policymakers for including a groundbreaking quantum pilot program, dedicated to near-term quantum computing applications, as part of the National Defense Authorization Act (“NDAA”) … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) the West’s Strategy to Weaken China’s Minerals Dominance with its RapidSX(TM) Technology

Posted on January 5, 2024 by MissionIR

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a company engaged in the exploration for and separation and scalable production of rare earth elements (“REEs”) in Canada and the U.S., understands the current state of the rare earths market, currently dominated … Continue reading →

Posted in Ucore Rare Metals Inc. UURAF | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Invoices $12M-Plus for Class 1, Class 3 EVs in 2023

Posted on January 4, 2024 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting on the status of its Class 1 and Class 3 vehicles for 2023. According to the announcement, the company delivered 100 Class 1 and 141 Class 3 vehicles … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Improve Oral Performance of Rybelsus(R)-Branded GLP-1 Drug Semaglutide

Posted on January 4, 2024 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced positive final results from its recently completed human Pilot Study #1 evaluating DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide available … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) CEO Releases Shareholder Letter

Posted on January 4, 2024 by MissionIR

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on development of inflammation and immunology (“I&I”) biological products, has released a letter from its CEO, Amir Reichman. In the letter, Reichman summarizes the company’s 2023 accomplishments and looks forward to 2024. According to the letter, … Continue reading →

Posted in Scinai Immunotherapeutics Ltd. SCNI | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reaches Class 3 Delivery Target for 2023 Calendar Year

Posted on January 3, 2024 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting that it reached its Class 3 target for the calendar year 2023. According to the announcement, the company built 154 Class 3 vehicles and delivered 141 Class 3 … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment